January 16, 2025

FDA Clears First Nicotine Pouches for U.S. Market

FDA grants first-ever marketing authorization for ZYN nicotine pouches following a scientific review that showed lower health risks compared to traditional tobacco products and minimal youth usage.

Conexiant

January 15, 2025

FDA to Revoke Red No. 3

Red No. 3 is found in many popular food items, including Pop Tarts, Dole Fruit Packs, Double Bubble Gum, Peeps, and more.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Lung Cancer's Paradox: Never-Smokers Outlive Smokers?

New research challenges conventional wisdom as never-smokers with NSCLC present with more advanced disease but achieve median survival of 6.6 years versus 3.9 years in smokers, upending traditional prognostic assumptions.

Conexiant

January 15, 2025

PRKG2: Genetic Link Between SSc and LUAD

PRKG2 expression reveals genetic ties between systemic sclerosis and lung adenocarcinoma.

Conexiant

January 15, 2025

FDA Proposes Nicotine Limits for Tobacco

The US Food and Drug Administration has introduced a proposal to cap nicotine levels in cigarettes, with the goal of curbing addiction, reducing smoking rates, and averting millions of tobacco-related deaths by 2100.

Conexiant

January 14, 2025

Even Low Levels of ctDNA May Be Linked to Recurrence Risk in Early Lung Cancer, Study Finds

A recent study published by Black et al in Nature Medicine has found that very low traces of circulating tumor DNA (ctDNA) may be linked to increased recurrence risk in patients with early-stage lung ...

The ASCO Post

January 14, 2025

ADRIATIC Trial: Durvalumab Consolidation Extends Survival in Limited-Stage Small Cell Lung Cancer

Consolidation therapy with the PD-1 immune checkpoint inhibitor durvalumab is set to become the new global standard of care for patients with limited-stage small cell lung cancer, according to groundb...

The ASCO Post

January 14, 2025

Metformin May Impact Immunotherapy in NSCLC

Metformin may strengthen the effects of immunotherapy and improve recurrence-free survival in patients with lung cancer with overweight or obesity, according to a recently published article in the Jou...

The ASCO Post